CMR Short Reviews
- The Concept of CMR
  Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.
- Evaluating CMR
  Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).
- Managing CMR
  Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.
Documentation Centre
- Slides, videos and more

News

6 result(s) found

Results 1 to 5

February 03, 2012Cardiovascular Disease, Clinical Trials, Lipids/Lipoproteins, News
High-density lipoprotein cholesterol as the Holy Grail. JAMA 2011;306:2153-5: Cannon CP.

February 03, 2012Cardiovascular Disease, Hypertension , Lipids/Lipoproteins, News
Cardiology in 2011--amazing opportunities, huge challenges. JAMA 2011;306:2158-9: Peterson ED, Gaziano JM.

February 03, 2012Cardiovascular Disease, Lipids/Lipoproteins, News, Prevention
Statin therapy in primary CVD prevention remains a hot-button topic for some. JAMA 2011;306:2077-8: Mitka M.

February 02, 2012Cardiovascular Disease, Clinical Trials, Hypertension , News
Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA 2011;306:2137-44: Ovbiagele B, Diener HC, Yusuf S, Martin RH, Cotton D, Vinisko R, Donnan GA, Bath PM; PROFESS Investigators.

February 02, 2012Cardiovascular Disease, News, Nutrition, Prevention
Prevention of cardiovascular disease and stroke: meeting the challenge. JAMA 2011;306:2147-8: Tomaselli GF.

6 result(s) found

Results 1 to 5

The content of this website is provided for educational and informational purposes only and is not to be used for medical advice, diagnosis or treatment. Use of this site is subject to the terms and conditions contained in our Legal Notices.